Phase 2 trial of INT301 in Peanut Allergic Children
Latest Information Update: 29 Sep 2022
At a glance
- Drugs INT 301 (Primary)
- Indications Peanut hypersensitivity
- Focus Therapeutic Use
Most Recent Events
- 29 Sep 2022 New trial record
Latest Information Update: 29 Sep 2022